NeuroOne Medical Technologies
NMTC
10 hedge funds and large institutions have $394K invested in NeuroOne Medical Technologies in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
0.23% less ownership
Funds ownership: 0.73% → 0.49% (-0.23%)
9% less funds holding
Funds holding: 11 → 10 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
49% less capital invested
Capital invested by funds: $777K → $394K (-$383K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCIA
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
|
+$49.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.01K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$818 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$273K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38K |
| 3 |
VF
Virtu Financial
New York
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $197K | – | – | – |
|
|
DWM
2
Drive Wealth Management
Lehi,
Utah
| $55K | – | – | – |
|
|
KCIA
3
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
| $44K | +$49.5K | +8,901 | New |
|
|
IC
4
Intersect Capital
San Ramon,
California
| $41K | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $39K | +$10.6K | +1,911 | +31% |
|
6
Northern Trust
Chicago,
Illinois
| $13K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4K | +$5.01K | +901 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | +$818 | +147 | New |
|
|
SCM
9
Stonepine Capital Management
Bend,
Oregon
| – | -$273K | -41,351 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$38K | -5,796 | Closed |
|
|
VF
11
Virtu Financial
New York
| – | -$17K | -2,581 | Closed |
|
|
12
Wells Fargo
San Francisco,
California
| – | +$11 | +2 | +15% |
|
NMTC Hedge Fund Activity: Q2 2022 in Review
10 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q2 2022, worth a combined $394K — down 49% from $777K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NMTC and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Kingsbury Capital Investment Advisors, opening a new position worth an estimated $49.5K. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $273K sold.
- 10 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q2 2022, down from 11 in Q1 2022.
- Funds reported $394K of NeuroOne Medical Technologies stock for Q2 2022, down 49% quarter-over-quarter.
- 3 funds opened new NeuroOne Medical Technologies positions in Q2 2022 and 4 closed out, a net change of -1 holder.
- The largest NeuroOne Medical Technologies buyer in Q2 2022 was Kingsbury Capital Investment Advisors, an estimated $49.5K added.
- The largest NeuroOne Medical Technologies seller in Q2 2022 was Stonepine Capital Management, an estimated $273K sold.
Based on aggregated 13F filings for Q2 2022.